Gianakakos Anastasios
President and CEO at MyoKardia Inc; SVP, Chief Business Officer at MAP Pharmaceuticals, Inc.
- Sold, on record
- $16.9M
- Dollars the filings state
- Form 4 sales
- 90
- Latest Jul 2, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MyoKardia IncPresident and CEO
- MAP Pharmaceuticals, Inc.SVP, Chief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MAP Pharmaceuticals, Inc.241,279 shares
- MyoKardia Inc221,057 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MyoKardia IncPlan not statedApr 2, 2020 2020
Sold 2,500 shares at $44.77 ($112k)
Gianakakos Anastasios, President and CEO
Sold 3.1% of holdings ($3.7M position)79,296 shares left0.8x usual sizeFiling
- 2 Form 4 sale MyoKardia IncPlan not statedApr 8, 2020 +6 days
Sold 1,500 shares at $50.00 ($75k)
Gianakakos Anastasios, President and CEO
Sold 1.9% of holdings ($4M position)77,796 shares left0.5x usual sizeFiling
- 3 Form 4 sale MyoKardia IncPlan not statedApr 16, 2020 +8 days
Sold 1,000 shares at $55.00 ($55k)
Gianakakos Anastasios, President and CEO
Sold 1.3% of holdings ($4.3M position)76,796 shares left0.3x usual sizeFiling
- 4 Form 4 sale MyoKardia IncPlan not statedMay 4, 2020 +18 days
Sold 5,000 shares at $58.48 ($292k)
Gianakakos Anastasios, President and CEO
Sold 6.3% of holdings ($4.6M position)74,122 shares left1.7x usual sizeFiling
- 5 Form 4 sale MyoKardia IncUnusualMay 11, 2020 +7 days
Sold 25,000 shares at $101.86 ($2.5M)
Gianakakos Anastasios, President and CEO
Sold 39% of holdings ($6.5M position)39,122 shares left8.3x usual sizeFiling
- 6 Form 4 sale MyoKardia IncUnusualMay 18, 2020 +7 days
Sold 10,000 shares at $125.00 ($1.3M)
Gianakakos Anastasios, President and CEO
Sold 25.6% of holdings ($4.9M position)29,122 shares left3.3x usual sizeFiling
- 7 Form 4 sale MyoKardia IncPlan not statedJun 2, 2020 +15 days
Sold 5,000 shares at $102.84 ($514k)
Gianakakos Anastasios, President and CEO
Sold 17.2% of holdings ($3M position)24,122 shares left1.4x usual sizeFiling
- 8 Form 4 sale MyoKardia IncPlan not statedJul 2, 2020 +30 days
Sold 5,000 shares at $93.98 ($470k)
Gianakakos Anastasios, President and CEO
Sold 20.7% of holdings ($2.3M position)19,122 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (90)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2020 | Jul 7, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $470k | 20.7% | Plan not stated | SEC |
| Jun 2, 2020 | Jun 4, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $514k | 17.2% | Plan not stated | SEC |
| May 18, 2020 | May 20, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 10,000 | $1.3M | 25.6% | Unusual | SEC |
| May 11, 2020 | May 13, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 25,000 | $2.5M | 39.0% | Unusual | SEC |
| May 4, 2020 | May 6, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $292k | 6.3% | Plan not stated | SEC |
| Apr 16, 2020 | Apr 20, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 1,000 | $55k | 1.3% | Plan not stated | SEC |
| Apr 8, 2020 | Apr 10, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 1,500 | $75k | 1.9% | Plan not stated | SEC |
| Apr 2, 2020 | Apr 6, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 2,500 | $112k | 3.1% | Plan not stated | SEC |
| Mar 2, 2020 | Mar 4, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $322k | 5.8% | Plan not stated | SEC |
| Feb 3, 2020 | Feb 5, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $347k | 5.4% | Plan not stated | SEC |
| Jan 14, 2020 | Jan 14, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $377k | 5.2% | Plan not stated | SEC |
| Jan 6, 2020 | Jan 7, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 12,687 | $868k | 11.6% | Unusual | SEC |
| Jan 3, 2020 | Jan 3, 2020 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $359k | 4.4% | Plan not stated | SEC |
| Dec 2, 2019 | Dec 4, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $325k | 5.5% | Plan not stated | SEC |
| Nov 4, 2019 | Nov 6, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $295k | 5.2% | Plan not stated | SEC |
| Oct 3, 2019 | Oct 4, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $264k | 4.9% | Plan not stated | SEC |
| Sep 11, 2019 | Sep 12, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 1,000 | $55k | 1.0% | Plan not stated | SEC |
| Sep 3, 2019 | Sep 5, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 4,000 | $209k | 3.8% | Plan not stated | SEC |
| Aug 8, 2019 | Aug 9, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 1,000 | $55k | 0.9% | Plan not stated | SEC |
| Aug 2, 2019 | Aug 5, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 4,000 | $213k | 3.6% | Plan not stated | SEC |
| Jul 22, 2019 | Jul 23, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 1,000 | $55k | 0.9% | Plan not stated | SEC |
| Jul 5, 2019 | Jul 8, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 4,000 | $199k | 3.4% | Plan not stated | SEC |
| Jan 7, 2019 | Jan 11, 2019 | MyoKardia Inc | President and CEO | Form 4 sale | 2,770 | $122k | 3.5% | Plan not stated | SEC |
| Dec 12, 2018 | Dec 13, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $167k | 4.0% | Plan not stated | SEC |
| Nov 5, 2018 | Nov 6, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $170k | 3.8% | Plan not stated | SEC |
| Oct 4, 2018 | Oct 5, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $175k | 3.8% | Plan not stated | SEC |
| Sep 4, 2018 | Sep 6, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $178k | 3.8% | Plan not stated | SEC |
| Aug 6, 2018 | Aug 8, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $172k | 3.8% | Plan not stated | SEC |
| Jul 5, 2018 | Jul 6, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $159k | 3.8% | Plan not stated | SEC |
| Jun 4, 2018 | Jun 6, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $141k | 3.8% | Plan not stated | SEC |
| May 4, 2018 | May 7, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $143k | 3.8% | Plan not stated | SEC |
| Apr 4, 2018 | Apr 5, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $144k | 3.9% | Plan not stated | SEC |
| Mar 5, 2018 | Mar 7, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $183k | 3.9% | Plan not stated | SEC |
| Feb 26, 2018 | Feb 28, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $300k | 6.3% | Plan not stated | SEC |
| Feb 5, 2018 | Feb 7, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $153k | 3.9% | Plan not stated | SEC |
| Jan 12, 2018 | Jan 16, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 5,000 | $250k | 1.0% | Plan not stated | SEC |
| Jan 4, 2018 | Jan 5, 2018 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $125k | 0.6% | Plan not stated | SEC |
| Dec 21, 2017 | Dec 26, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 3,000 | $123k | 0.6% | Plan not stated | SEC |
| Nov 6, 2017 | Nov 8, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 4,300 | $173k | 0.8% | Plan not stated | SEC |
| Oct 4, 2017 | Oct 6, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 4,300 | $176k | 0.8% | Plan not stated | SEC |
| Sep 5, 2017 | Sep 7, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 4,300 | $185k | 0.8% | Plan not stated | SEC |
| Aug 4, 2017 | Aug 4, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 4,300 | $71k | 0.8% | Plan not stated | SEC |
| Jul 25, 2017 | Jul 27, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 32,988 | $495k | 6.1% | Plan not stated | SEC |
| Mar 20, 2017 | Mar 22, 2017 | MyoKardia Inc | President and CEO | Form 4 sale | 1,412 | $21k | 0.3% | Plan not stated | SEC |
| Feb 28, 2013 | Mar 4, 2013 | MAP Pharmaceuticals, Inc. | SVP, Chief Business Officer | Form 4 sale | 20,000 | $500k | 52.0% | Unusual | SEC |
| Jan 23, 2013 | Jan 25, 2013 | MAP Pharmaceuticals, Inc. | SVP, Chief Business Officer | Form 4 sale | 30,000 | $743k | 67.7% | Unusual | SEC |
| Nov 1, 2012 | Nov 5, 2012 | MAP Pharmaceuticals, Inc. | SVP, Chief Business Officer | Form 4 sale | 5,767 | $90k | 31.8% | Unusual | SEC |
| Apr 2, 2012 | Apr 4, 2012 | MAP Pharmaceuticals, Inc. | SVP, Chief Business Officer | Form 4 sale | 2,500 | $36k | 16.8% | Plan not stated | SEC |
| Mar 9, 2012 | Mar 13, 2012 | MAP Pharmaceuticals, Inc. | SVP, Chief Business Officer | Form 4 sale | 10,000 | $175k | 44.7% | Unusual | SEC |
| Feb 21, 2012 | Feb 22, 2012 | MAP Pharmaceuticals, Inc. | SVP & Chief Business Officer | Form 4 sale | 2,500 | $40k | 16.8% | Plan not stated | SEC |
| Feb 6, 2012 | Feb 7, 2012 | MAP Pharmaceuticals, Inc. | SVP & Chief Business Officer | Form 4 sale | 10,000 | $150k | 44.7% | Unusual | SEC |
| Jan 19, 2012 | Jan 20, 2012 | MAP Pharmaceuticals, Inc. | SVP & Chief Business Officer | Form 4 sale | 4,471 | $62k | 32.4% | Unusual | SEC |
| Dec 12, 2011 | Dec 14, 2011 | MAP Pharmaceuticals, Inc. | SVP & Chief Bus Officer | Form 4 sale | 1,341 | $131k | 12.6% | Plan not stated | SEC |
| Aug 1, 2011 | Aug 3, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $23k | 13.9% | Plan not stated | SEC |
| Jul 1, 2011 | Jul 5, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $24k | 13.9% | Plan not stated | SEC |
| Jun 1, 2011 | Jun 3, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $25k | 13.9% | Plan not stated | SEC |
| May 9, 2011 | May 10, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 5,000 | $85k | 34.9% | Unusual | SEC |
| May 2, 2011 | May 3, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $23k | 13.9% | Plan not stated | SEC |
| Apr 1, 2011 | Apr 4, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $21k | 13.9% | Plan not stated | SEC |
| Mar 1, 2011 | Mar 2, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 1,500 | $24k | 13.9% | Plan not stated | SEC |
| Feb 1, 2011 | Feb 3, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 2,500 | $39k | 21.2% | Plan not stated | SEC |
| Jan 3, 2011 | Jan 4, 2011 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 2,500 | $42k | 28.1% | Unusual | SEC |
| Dec 15, 2010 | Dec 17, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 2,500 | $37k | 28.1% | Unusual | SEC |
| Sep 1, 2010 | Sep 3, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $36k | 33.7% | Unusual | SEC |
| Aug 2, 2010 | Aug 2, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $44k | 33.7% | Unusual | SEC |
| Jul 1, 2010 | Jul 2, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $41k | 33.7% | Unusual | SEC |
| Jun 1, 2010 | Jun 3, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $47k | 33.7% | Unusual | SEC |
| May 3, 2010 | May 5, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $59k | 33.7% | Unusual | SEC |
| Apr 1, 2010 | Apr 5, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $52k | 33.7% | Unusual | SEC |
| Mar 1, 2010 | Mar 3, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 3,250 | $46k | 33.7% | Unusual | SEC |
| Feb 1, 2010 | Feb 3, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 8,250 | $123k | 56.3% | Unusual | SEC |
| Jan 15, 2010 | Jan 19, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 5,000 | $75k | 87.3% | Unusual | SEC |
| Jan 4, 2010 | Jan 6, 2010 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 4,500 | $45k | 86.1% | Unusual | SEC |
| Dec 1, 2009 | Dec 2, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 4,500 | $41k | 86.1% | Unusual | SEC |
| Nov 2, 2009 | Nov 4, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 4,500 | $36k | 86.1% | Unusual | SEC |
| Oct 1, 2009 | Oct 5, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 4,500 | $46k | 86.1% | Unusual | SEC |
| Sep 8, 2009 | Sep 10, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 4,500 | $45k | 86.1% | Unusual | SEC |
| Jul 10, 2009 | Jul 14, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 25,000 | $254k | 97.2% | Unusual | SEC |
| Feb 4, 2009 | Feb 5, 2009 | MAP Pharmaceuticals, Inc. | SVP, Cor & Business Dev | Form 4 sale | 15,000 | $180k | 100.0% | Unusual | SEC |
| Jul 7, 2008 | Jul 8, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 600 | $6k | 100.0% | Unusual | SEC |
| Jul 3, 2008 | Jul 7, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 3,000 | $30k | 100.0% | Unusual | SEC |
| Jul 2, 2008 | Jul 7, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 2,200 | $22k | 100.0% | Unusual | SEC |
| Jul 1, 2008 | Jul 2, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 3,900 | $40k | 100.0% | Unusual | SEC |
| Jun 4, 2008 | Jun 5, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 3,500 | $44k | 100.0% | Unusual | SEC |
| Jun 3, 2008 | Jun 4, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 2,500 | $30k | 100.0% | Unusual | SEC |
| Jun 2, 2008 | Jun 3, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 4,000 | $49k | 100.0% | Unusual | SEC |
| May 19, 2008 | May 20, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 1,700 | $19k | 100.0% | Unusual | SEC |
| May 16, 2008 | May 20, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 5,300 | $61k | 100.0% | Unusual | SEC |
| May 15, 2008 | May 19, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 600 | $7k | 100.0% | Unusual | SEC |
| May 15, 2008 | May 19, 2008 | MAP Pharmaceuticals, Inc. | SVP, COR & Business Dev | Form 4 sale | 7,400 | $88k | 92.5% | Unusual | SEC |